• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Billiontoone Inc (BLLN)

Common Shares
Sell: $75.00|Buy: $88.00|Change: 6.14 (7.74%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates(QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Address




Website

https://www.billiontoone.com

Sector 

Healthcare

Forecast key dates

NameKey Date
BillionToOne Inc Annual Report for 20272027-03-11T00:00:00
BillionToOne Inc Fourth Quarter Earnings Conference Call for 20262027-03-04T16:30:00
BillionToOne Inc Fourth Quarter Earnings Results for 20262027-03-04T00:00:00
BillionToOne Inc Third Quarter Earnings Result for 20262026-11-30T00:00:00
BillionToOne Inc Third Quarter Earnings Conference Call for 20262026-11-30T00:00:00
BillionToOne Inc Second Quarter Earnings Result for 20262026-08-31T00:00:00
BillionToOne Inc Second Quarter Earnings Conference Call for 20262026-08-31T00:00:00
BillionToOne Inc First Quarter Earnings Result for 20262026-05-29T00:00:00
BillionToOne Inc First Quarter Earnings Conference Call for 20262026-05-29T00:00:00
BillionToOne Inc Annual General Meeting for 20262026-04-30T00:00:00

Previous key dates

NameKey Date
BillionToOne Inc Annual General Meeting for 20262026-04-30T00:00:00
BillionToOne Inc Annual Report for 20262026-03-11T00:00:00
BillionToOne Inc Fourth Quarter Earnings Conference Call for 20252026-03-04T16:30:00
BillionToOne Inc Fourth Quarter Earnings Results for 20252026-03-04T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.